2,525
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Development of new TAK-285 derivatives as potent EGFR/HER2 inhibitors possessing antiproliferative effects against 22RV1 and PC3 prostate carcinoma cell lines

, , , ORCID Icon, , , , , , , & show all
Article: 2202358 | Received 06 Feb 2023, Accepted 07 Apr 2023, Published online: 25 Apr 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ahmed A Gaber, Marwa Sharaky, Ayman Abo Elmaaty, Mohamed M Hammouda, Ahmed AE Mourad, Samy Y Elkhawaga, Mahmoud Mohamed Mokhtar, Amr S Abouzied, Mai AE Mourad & Ahmed A Al-Karmalawy. (2023) Design and Synthesis of Novel Pyrazolopyrimidine Candidates As Promising EGFR-T790M Inhibitors and Apoptosis Inducers. Future Medicinal Chemistry 15:19, pages 1773-1790.
Read now

Articles from other publishers (1)

Eslam M. Abbass, Ahmed A. Al-Karmalawy, Marwa Sharaky, Muhammad Khattab, Abdullah Yahya Abdullah Alzahrani & Aya I. Hassaballah. (2024) Rational design and eco-friendly one-pot multicomponent synthesis of novel ethylidenehydrazineylthiazol-4(5H)-ones as potential apoptotic inducers targeting wild and mutant EGFR-TK in triple negative breast cancer. Bioorganic Chemistry 142, pages 106936.
Crossref